NextGen Omics Series US

Dec 03, 2020 02:25 PM to Dec 04, 2020 11:00 PM (Europe/Zurich)


Odoo • Image and Text

Delivering therapeutic innovation, applications and technologies in next generation sequencing, single cell analysis and genome editing

Bringing together leading omics experts from around the world and comprised of three outstanding programmes, delegates can expect to benefit from critical discussions and case studies shaping the future of Next Generation Sequencing, Multi-omic Single Cell Analysis (including spatial transcriptomics) and Genome Editing in Drug Discovery & Therapeutic Development. 

Odoo • Text and Image
Odoo • Text and Image

Boost CRISPR efficiency by fast and easy multiplex genome editing

Our unique FluidFM BIO Series, a highly automated solution for single-cell manipulation coupled to a Olympus IX83 inverted fluorescence microscope, delivers all CRISPR components, or any other cargo, simultaneously and at defined concentration directly into the nucleus whilst maintaining high cell viability. This paves the way to use large templates and to easy multiplex- and stack-editing. The system also enables optimization of off-target effects and HDR efficiency as the quantity of injected copies can be calculated and therefore dose/response relationships investigated. The injection process is highly automated and reproducible with an intuitive user interface – perform direct delivery with a simple mouse click.

Seeing is believing – We look forward to meeting you at our virtual booth and discussing how we can help you to optimize your CRISPR experiments.


Odoo CMS - a big picture

Meet us online

Participating from Cytosurge:
Dr. Matyas Vegh, CCO
Dr. Pablo Dörig, VP Research Solutions
Dr. Paul Monnier, Field Application Scientist

Presentation
"FluidFM: a novel and fast approach to CRISPR gene editing" by Dr. Paul Monnier, Field Application Scientist
December 4, 09:00 - 09:30 (EST) / 15:00 - 15:30 (CET)
Track 8: Genome editing discovery & therapeutics

Roundtable
"CRISPR Multiplex Editing" moderated by  Dr. Paul Monnier, Field Application Scientist
- Applications that benefit from CRISPR multiplexing
- Outstanding challenges in CRISPR multiplexing – delivery, DNA damage response, etc.
- Future scientific directions
December 4, 11:00 - 11:30 (EST) / 17:00 - 17:30 (CET)

If you wish to have a scheduled meeting during the event, kindly send an e-mail to:
Dr. Matyas Vegh, CCO

    When

    From Dec 03, 2020 02:25 PM
    To Dec 04, 2020 11:00 PM

    Organizer

    Oxford Global Marketing Ltd
    +44 1865 248455
    info@oxfordglobal.co.uk

    Social Stream

    Subscribe to our Newsletter


    Participate on Twitter

    Find out what people see and say about this event, and join the conversation.

    Use this tag:#NextGenOmics

    Following content will appear on all events